These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 8791027

  • 1. Inhibition of the trigemino-vascular system with 5-HT1D agonist drugs: selectively targeting additional sites of action.
    Martin GR.
    Eur Neurol; 1996; 36 Suppl 2():13-8. PubMed ID: 8791027
    [Abstract] [Full Text] [Related]

  • 2. Pre-clinical pharmacology of zolmitriptan (Zomig; formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraine.
    Martin GR.
    Cephalalgia; 1997 Oct; 17 Suppl 18():4-14. PubMed ID: 9399012
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Extending therapeutic options? Prospects for the future.
    Edmeads JG.
    Eur Neurol; 1996 Oct; 36 Suppl 2():32-3. PubMed ID: 8791031
    [No Abstract] [Full Text] [Related]

  • 7. 311C90, a new central and peripherally acting 5-HT1D receptor agonist in the acute oral treatment of migraine: a double-blind, placebo-controlled, dose-range finding study.
    Visser WH, Klein KB, Cox RC, Jones D, Ferrari MD.
    Neurology; 1996 Feb; 46(2):522-6. PubMed ID: 8614525
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of the long-term safety and efficacy of 311C90 in the treatment of migraine.
    Geraud GE.
    Eur Neurol; 1996 Feb; 36 Suppl 2():24-7. PubMed ID: 8791029
    [Abstract] [Full Text] [Related]

  • 10. 311C90 (Zolmitriptan), a novel centrally and peripheral acting oral 5-hydroxytryptamine-1D agonist: a comparison of its absorption during a migraine attack and in a migraine-free period.
    Thomsen LL, Dixon R, Lassen LH, Gibbens M, Langemark M, Bendtsen L, Daugaard D, Olesen J.
    Cephalalgia; 1996 Jun; 16(4):270-5. PubMed ID: 8792040
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical applications of zolmitriptan (Zomig, 311C90).
    Lipton RB, Stewart WF.
    Cephalalgia; 1997 Oct; 17 Suppl 18():53-9. PubMed ID: 9399017
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Mechanism of action of zolmitriptan].
    Pascual J.
    Neurologia; 1998 Oct; 13 Suppl 2():9-15. PubMed ID: 9859690
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Emerging preclinical and clinical profile of 311C90: a poster review and discussion.
    Ferrari MD.
    Eur Neurol; 1996 Oct; 36 Suppl 2():19-23. PubMed ID: 8791028
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.